Efficacy and Safety of Belimumab, Anifrolumab, and Telitacicept on the Treatment of Systemic Lupus Erythematosus: a Network Meta-analysis
Background Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease. At present, three biological agents have been approved for treating SLE, including belimumab, anifrolumab, and telitacicept. However, a direct comparison of their efficacy and safety is lacking. Objective To a...
Sábháilte in:
| Príomhchruthaitheoir: | |
|---|---|
| Formáid: | Artigo |
| Teanga: | Chinês |
| Foilsithe / Cruthaithe: |
Chinese General Practice Publishing House Co., Ltd
2025-08-01
|
| Sraith: | Zhongguo quanke yixue |
| Ábhair: | |
| Rochtain ar líne: | https://www.chinagp.net/fileup/1007-9572/PDF/20230864.pdf |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|